Esperanza
Martín Sanchez
Investigadora
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublications in collaboration with researchers from Hospital Universitario Marqués de Valdecilla (6)
2022
-
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781
2014
-
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
Modern Pathology, Vol. 27, Núm. 10, pp. 1331-1337
-
PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases
PLoS ONE, Vol. 9, Núm. 11
-
PLCG1 mutations in cutaneous T-cell lymphomas
Blood, Vol. 123, Núm. 13, pp. 2034-2043
2013
-
NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells
Clinical Cancer Research, Vol. 19, Núm. 9, pp. 2319-2330
-
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
Haematologica, Vol. 98, Núm. 1, pp. 57-64